fashion -WSS

fashion

author：hotspot 2025-09-03 09:28:07 - browse：16

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Midwives could help bridge maternal health disparities in the U.S.

explore

WSS

Resistance to cancer drugs: A new genetic explanation

'A game

Why the Crimean Bridge is key to Russia's war in Ukraine

Why the Crimean Bridge is key to Russia's war in Ukraine

Patients, doctors press FTC to beef up hospital merger scrutiny

Eli Lilly CEO gives to Mike Pence presidential super PAC

explore

fashion

knowledge

Sports medicine is finally prioritizing gender equality

'Reaching a detente': STAT's Helen Branswell on covering Covid

Heart attack and stroke risk calculators need revising

'Reaching a detente': STAT's Helen Branswell on covering Covid

Continuity nursing helped my family in our darkest PICU moments

The struggle to figure out which patients 'deserve' Wegovy

Sports medicine is finally prioritizing gender equality

Celebrate National Dole Whip Day for 3 days this week at Disney

BioMarin wins approval for gene therapy to treat hemophilia A

Transgender sports debate: Physicians say bans are health issue

focus

Information blocking fines are now fair game in health care

Resistance to cancer drugs: A new genetic explanation

Ebola public health emergency is over, WHO declares

Assistant physicians can help address the primary care shortage

How the messy conversation about Dolly changed bioethics

Transgender sports debate: Physicians say bans are health issue

entertainment

explore

focus

Wikipedia